Medeon Biodesign (6499) — Net Asset Momentum
Medeon Biodesign (6499) recorded a net asset momentum of 0.1% as of December 2025, with net assets of NT$1.54 Billion TWD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 6499 net asset value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Medeon Biodesign Net Asset Momentum (2017–2025)
This chart tracks Medeon Biodesign's year-over-year net asset growth across 9 annual reporting periods from 2017 to 2025. The most recent momentum reading is +0.1%, with net assets of NT$1.54 Billion TWD as of December 2025. For live market cap and overall valuation, see market cap of Medeon Biodesign.
Annual Net Asset History for Medeon Biodesign (2017–2025)
The table below shows the complete annual net asset history for Medeon Biodesign from 2017 to 2025, covering 9 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check how tangible is Medeon Biodesign's equity to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (TWD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | NT$1.54 Billion | NT$1.78 Billion | NT$243.03 Million | ▲ +0.1% |
| 2024 | NT$1.54 Billion | NT$1.88 Billion | NT$341.84 Million | ▼ -35.2% |
| 2023 | NT$2.37 Billion | NT$2.75 Billion | NT$375.65 Million | ▼ -35.3% |
| 2022 | NT$3.66 Billion | NT$4.04 Billion | NT$376.48 Million | ▼ -12.5% |
| 2021 | NT$4.19 Billion | NT$4.36 Billion | NT$176.00 Million | ▲ +58.2% |
| 2020 | NT$2.65 Billion | NT$3.31 Billion | NT$666.83 Million | ▲ +17.7% |
| 2019 | NT$2.25 Billion | NT$2.52 Billion | NT$268.18 Million | ▲ +25.0% |
| 2018 | NT$1.80 Billion | NT$1.95 Billion | NT$148.89 Million | ▲ +17.3% |
| 2017 | NT$1.53 Billion | NT$1.64 Billion | NT$105.41 Million | — |